Recce Pharmaceuticals (ASX:RCE) has confirmed its completion of the latest fast-infusion study using its R327 anti-infective as an IV drug. LATEST: Placement & SPP to raise $10 million - Funded to FY26.
ResMed shares have climbed following the release of the company's strong Third Quarter FY2024 results.
26 Apr 2024 13:45 (AEST)
Cloud-connected medical devices creator ResMed (ASX:RMD) has published its results for the first quarter of the 2024 fiscal year.
27 Oct 2023 12:02 (AEDT)
ResMed (ASX:RMD) has announced its financial results for Q4 FY23, highlighting RMD revenue increased by 23 per cent to $1.1 billion.
04 Aug 2023 11:26 (AEST)
ResMed (ASX:RMD) CEO Michael Farrell takes over the role of Chairman from his father, Peter Farrell, as company profit soars.
27 Jan 2023 13:48 (AEDT)
Uranium was one bright spot at the start of 2024, standing out against otherwise glum markets that defined 2023.